"SARS-Covid-2" の関連情報検索結果

SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine



SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina  Yale School of Medicine

Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic ...



Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target  Nature

Nimbus COVID: Definition, symptoms, and more - Medical News Today



Nimbus COVID: Definition, symptoms, and more  Medical News Today

Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-media...



Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition  ScienceDirect.com

2023 to 2024 COVID-19 Vaccine Provided Additional Effectiveness - Hematology Advisor



2023 to 2024 COVID-19 Vaccine Provided Additional Effectiveness  Hematology Advisor

XFG could become the next dominant COVID variant. Here’s what to know about ‘Stratus’ - The Conve...



XFG could become the next dominant COVID variant. Here’s what to know about ‘Stratus’  The Conversation

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...



Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID  Johns Hopkins Medicine

COVID-NET - Centers for Disease Control and Prevention | CDC (.gov)



COVID-NET  Centers for Disease Control and Prevention | CDC (.gov)

New antisense oligonucleotide as broad-spectrum antiviral against SARS-CoV-2 - BioWorld MedTech



New antisense oligonucleotide as broad-spectrum antiviral against SARS-CoV-2  BioWorld MedTech

Why Long COVID May Hit Toddlers Harder Than Thought - Medscape



Why Long COVID May Hit Toddlers Harder Than Thought  Medscape

Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses...



Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort  Nature

Testing for COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)



Testing for COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Cognitive impairment 2 years after mild to severe SARS-CoV-2 infection in a population-based stud...



Cognitive impairment 2 years after mild to severe SARS-CoV-2 infection in a population-based study with matched-comparison groups  Nature

COVID-19 | Yellow Book - Centers for Disease Control and Prevention | CDC (.gov)



COVID-19 | Yellow Book  Centers for Disease Control and Prevention | CDC (.gov)

Long COVID after SARS-CoV-2 during pregnancy in the United States - Nature



Long COVID after SARS-CoV-2 during pregnancy in the United States  Nature

Applications and research trends in organoid based infectious disease models - Nature



Applications and research trends in organoid based infectious disease models  Nature

Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunction...



Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs  Nature

Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using ...



Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records  Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic - Nature



Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic  Nature

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein - Nature



A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein  Nature

SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review a...



SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis  Nature

Staying Up to Date with COVID-19 Vaccines - Centers for Disease Control and Prevention | CDC (.gov)



Staying Up to Date with COVID-19 Vaccines  Centers for Disease Control and Prevention | CDC (.gov)

COVID is still evolving and will find new ways to evade immune systems, scientists say - NPR



COVID is still evolving and will find new ways to evade immune systems, scientists say  NPR

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature



Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron  Nature

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...



SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows  Centers for Disease Control and Prevention | CDC (.gov)

The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory ...



The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells  Nature

Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection - Nature



Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection  Nature

Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease - Nature



Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease  Nature

A Patient With Three Types of Hematologic Disorders and Hemophagocytic Lymphohistiocytosis Trigge...



A Patient With Three Types of Hematologic Disorders and Hemophagocytic Lymphohistiocytosis Triggered by SARS-CoV-2: A Case Report  Cureus

Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic a...



Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture  Science | AAAS

Long COVID across SARS-CoV-2 variants: Clinical features, pathogenesis, and future directions - W...



Long COVID across SARS-CoV-2 variants: Clinical features, pathogenesis, and future directions  Wiley Online Library

Detection of SARS-CoV-2 in wastewater as an earlier predictor of COVID-19 epidemic peaks in Venez...



Detection of SARS-CoV-2 in wastewater as an earlier predictor of COVID-19 epidemic peaks in Venezuela  Nature

Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatme...



Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19  Nature

SARS-CoV-2 evolution on a dynamic immune landscape - Nature



SARS-CoV-2 evolution on a dynamic immune landscape  Nature

Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study - T...



Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study  The Lancet

SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential w...



SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study  The Lancet

How the virus behind COVID-19 can harm your blood vessels and your heart - www.heart.org



How the virus behind COVID-19 can harm your blood vessels and your heart  www.heart.org

Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages - EMB...



Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages  EMBO Press

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)



Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

SARS-CoV-2 variants induce increased inflammatory gene expression but reduced interferon response...



SARS-CoV-2 variants induce increased inflammatory gene expression but reduced interferon responses and heme synthesis as compared with wild type strains  Nature

Symptoms can predict COVID-19 pneumonia in patients infected with SARS-CoV-2 Omicron variants - N...



Symptoms can predict COVID-19 pneumonia in patients infected with SARS-CoV-2 Omicron variants  Nature

The virus that won’t quit: new research reveals how SARS-CoV-2 evolves - UNSW Sydney



The virus that won’t quit: new research reveals how SARS-CoV-2 evolves  UNSW Sydney

Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways - Cell Communication and...



Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways  Cell Communication and Signaling

Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...



Genomic Surveillance for SARS-CoV-2 Variants: ...  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compar...



SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination  Nature

The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats | Scientific Reports -...



The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats | Scientific Reports  Nature

COVID pandemic started in Wuhan market animals after all, suggests latest study - Nature



COVID pandemic started in Wuhan market animals after all, suggests latest study  Nature

COVID-19 and the Lungs - National Institutes of Health (NIH) | (.gov)



COVID-19 and the Lungs  National Institutes of Health (NIH) | (.gov)

Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable...



Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases  Nature

Changes in memory and cognition during the SARS-CoV-2 human challenge study - The Lancet



Changes in memory and cognition during the SARS-CoV-2 human challenge study  The Lancet

Pre-COVID health-related quality of life predicts symptoms and outcomes for patients with long CO...



Pre-COVID health-related quality of life predicts symptoms and outcomes for patients with long COVID  Frontiers

Lab Leak: The True Origins of Covid-19 - The White House (.gov)



Lab Leak: The True Origins of Covid-19  The White House (.gov)

KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases - Centers for Disease Control ...



KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases  Centers for Disease Control and Prevention | CDC (.gov)

Widespread exposure to SARS-CoV-2 in wildlife communities - Nature



Widespread exposure to SARS-CoV-2 in wildlife communities  Nature

Molecular architecture of coronavirus double-membrane vesicle pore complex - Nature



Molecular architecture of coronavirus double-membrane vesicle pore complex  Nature

Should we be worried about ‘Stratus’? The new Covid variant spreading fast - MSN



Should we be worried about ‘Stratus’? The new Covid variant spreading fast  MSN

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...



Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

Characteristics of SARS-CoV-2 and COVID-19 - Nature



Characteristics of SARS-CoV-2 and COVID-19  Nature

About COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)



About COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 in animals - American Veterinary Medical Association



SARS-CoV-2 in animals  American Veterinary Medical Association

Coronavirus disease (COVID-19) - World Health Organization (WHO)



Coronavirus disease (COVID-19)  World Health Organization (WHO)

SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (NIH) | (...



SARS-CoV-2 fragments may cause problems after infection  National Institutes of Health (NIH) | (.gov)

Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in...



Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands  ACS Publications

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 - ScienceDirect.com



Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19  ScienceDirect.com

COVID-19 (SARS-CoV-2 virus) - Institut Pasteur



COVID-19 (SARS-CoV-2 virus)  Institut Pasteur

SARS-CoV-2 and the Missing Link of Intermediate Hosts in Viral Emergence - What We Can Learn From...



SARS-CoV-2 and the Missing Link of Intermediate Hosts in Viral Emergence - What We Can Learn From Other Betacoronaviruses  Frontiers

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection - The New England...



Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection  The New England Journal of Medicine

Surveillance and Data Analytics | COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)



Surveillance and Data Analytics | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development - Frontiers



Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development  Frontiers

The evolution of SARS-CoV-2 - Nature



The evolution of SARS-CoV-2  Nature

SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature



SARS-CoV-2 infection and persistence in the human body and brain at autopsy  Nature

Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States - Nature



Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States  Nature

Mechanisms of SARS-CoV-2 entry into cells - Nature



Mechanisms of SARS-CoV-2 entry into cells  Nature

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...



SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels  Nature

Animals and COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)



Animals and COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis - ScienceDirect...



SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis  ScienceDirect.com

Severe Acute Respiratory Syndrome (SARS) - World Health Organization (WHO)



Severe Acute Respiratory Syndrome (SARS)  World Health Organization (WHO)

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature



SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)  Nature

A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment ...



A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19  ACS Publications

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 - The New England Journa...



Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19  The New England Journal of Medicine

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets - Nature



COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets  Nature

Using big sequencing data to identify chronic SARS-Coronavirus-2 infections - Nature



Using big sequencing data to identify chronic SARS-Coronavirus-2 infections  Nature

The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...



The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2  Nature

Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 - ScienceDirect.com



Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19  ScienceDirect.com

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients - ScienceDirect.com



Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients  ScienceDirect.com

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia - ScienceDirect.com



SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia  ScienceDirect.com

SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson’s disease in human dopaminer...



SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson’s disease in human dopaminergic neurons and a mouse model  ScienceDirect.com

Antibody responses to SARS-CoV-2 in patients with COVID-19 - Nature



Antibody responses to SARS-CoV-2 in patients with COVID-19  Nature

SARS-CoV-2 in Animals - aphis.usda.gov



SARS-CoV-2 in Animals  aphis.usda.gov

The proximal origin of SARS-CoV-2 - Nature



The proximal origin of SARS-CoV-2  Nature

SARS-CoV-2 and the Host Cell: A Tale of Interactions - Frontiers



SARS-CoV-2 and the Host Cell: A Tale of Interactions  Frontiers

SARS-CoV-2 pathogenesis - Nature



SARS-CoV-2 pathogenesis  Nature

The role of cell death in SARS-CoV-2 infection - Nature



The role of cell death in SARS-CoV-2 infection  Nature

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spe...



Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum  Nature

COVID-19 Resources (SARS-CoV-2 Coronavirus) - American Society for Microbiology



COVID-19 Resources (SARS-CoV-2 Coronavirus)  American Society for Microbiology

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks” | Cellular & Molecular Im...



SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks” | Cellular & Molecular Immunology  Nature

SARS-CoV-2 productively infects human gut enterocytes - Science | AAAS



SARS-CoV-2 productively infects human gut enterocytes  Science | AAAS

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexpos...



Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals  ScienceDirect.com

Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19 - Na...



Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19  Nature

How lung distress from SARS-CoV-2 can cause heart damage - National Institutes of Health (NIH) | ...



How lung distress from SARS-CoV-2 can cause heart damage  National Institutes of Health (NIH) | (.gov)